Table 2.
Efficacy outcomes.
Best response | Chemotherapy + simvastatin (n = 40) | Chemotherapy + placebo (n = 40) | P value |
---|---|---|---|
n (%) | |||
Complete response | 1 (2.5) | 4 (10) | 0.57 |
Partial response | 13 (32.5) | 9 (22.5) | |
Stable disease | 10 (25) | 11 (27.5) | |
Progressive disease | 14 (35) | 15 (37.5) | |
Not evaluable | 2 (5) | 1 (2.5) |
The assessment did not include the withdrawn consent patients (n = 2)